Pharmaceutical Prices Set To Fall

BMI View: Thailand's liberal pharmaceutical pricing regime is in need of reform. The current framework favours the interests of drugmakers over patient welfare, which is leading to societal discontent. As the country's economy expands and its political situation stabilises, we expect advocacy groups, non-government organisations (NGOs), academics, insurers and health economists to push for change.

To read the full article, please choose one of the following options: